IMMUNODEFICIENCY IN CANCER AND IMPORTANCE OF IMMUNE EVALUATION OF CANCER PATIENT

被引:43
作者
HERSH, EM [1 ]
MAVLIGIT, GM [1 ]
GUTTERMAN, JU [1 ]
机构
[1] UNIV TEXAS MD ANDERSON HOSP & TUMOR INST,CTR SYST CANC,DEPT DEV THERAPEUTICS,HOUSTON,TX 77025
关键词
D O I
10.1016/S0025-7125(16)31902-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:623 / 639
页数:17
相关论文
共 85 条
[51]   EFFECT OF TRANSFER FACTOR THERAPY ON TUMOR IMMUNITY IN ALVEOLAR SOFT PART SARCOMA [J].
LOBUGLIO, AF ;
NEIDHART, JA ;
HILBERG, RW ;
METZ, EN ;
BALCERZAK, SP .
CELLULAR IMMUNOLOGY, 1973, 7 (01) :159-165
[52]   COMPARISON OF EFFECTOR CELLS INVOLVED IN CELL-MEDIATED LYMPHOLYSIS AND ANTIBODY - DEPENDENT CELL-MEDIATED CYTOTOXICITY IN MAN [J].
MACDONALD, HR ;
BONNARD, GD .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1975, 4 (02) :129-138
[53]  
MAVLIGIT GM, 1974, CANCER, V34, P1712, DOI 10.1002/1097-0142(197411)34:5<1712::AID-CNCR2820340520>3.0.CO
[54]  
2-J
[56]   PLASMA FACTOR INHIBITING LYMPHOCYTE-REACTIVITY IN UROLOGIC CANCER-PATIENTS [J].
MCLAUGHLIN, AP ;
BROOKS, JD .
JOURNAL OF UROLOGY, 1974, 112 (03) :366-372
[57]  
MELLSTEDT H, 1973, CLIN EXP IMMUNOL, V15, P321
[58]  
MELLSTEDT H, 1973, CLIN EXP IMMUNOL, V15, P309
[59]   IMMUNOLOGICAL FACTORS IN HUMAN SARCOMAS AND MELANOMAS - A RATIONAL BASIS FOR IMMUNOTHERAPY [J].
MORTON, DL ;
EILBER, FR ;
JOSEPH, WL ;
WOOD, WC ;
TRAHAN, E ;
KETCHAM, AS .
ANNALS OF SURGERY, 1970, 172 (04) :740-&
[60]  
MURGITA RA, 1975, J EXP MED, V141, P440